吉兰-巴雷综合征免疫治疗的研究进展
The Development of Immunotheropy of Guillain-Barre Syndrome
摘要
大多认为吉兰-巴雷综合征(GBS)是自身免疫性周围神经病,大量临床试验证明,有效的免疫治疗可缩短住院时间并改善预后。最早发现的有效的免疫治疗方法是血浆置换,已成为GBS治疗试验疗效评价的参照;静脉注射免疫球蛋白为重型GBS患者的一线用药,尤其对儿童及植物神经功能紊乱患者更有意义;糖皮质激素的疗效颇有争议;脑脊液过滤可能是一种颇有前景的治疗方法;β干扰素从细胞免疫的角度为GBS的治疗提供了新的途径。
出处
《国外医学（儿科学分册）》
2005年第5期308-310,共3页
Foreign Medical Sciences（Section of Pediatrics)
参考文献22
-
1Raphael JC, Chevret S, Hughes RA,et al. Plasma exchange for Guillain-barre syndrome[ J]. Cochrane Database Syst Rev, 2002,22(2) : CD001798.
-
2Yang KS,Kenpe K,Yamaji K,et al. Plasma adsorption in critical care[J].Ther Apher,2002,6(3) : 184-188.
-
3Lindenbaum Y, Kissel Jr, MendellJR. Tr-eatment approaches for Guiooain-Barre syndromeand chronic inflammatory dem-yelinating polyradiculoneuropathy[ J]. Neurol Clin, 2001,19( 1 ) : 187-204.
-
4Hughea RA, Raphael JC, Swan AV, et al. Intravenous immunoglobulin for Guillain Bane syndrome [ J ]. Cochrane Database Syst Rev, 2001, ( 2 ) :CD002063.
-
5[No authors listed] Appropriate number of plasma exchange in Guillaln-Barre syndrome. The French Coopeative Group on Plasma Exchange in Guillain-Barre syndrome[J] .Ann Neurol, 1997,41 : (3) :298-306.
-
6Carbajal-Ramirez A, Castanon-Gonzalez JA, Osualdo-Talavera J, et al. Plasmaphe in Guillain-Barne syndrome [ J ]. Gac Med Mex, 2002, 138 (6) :527-531.
-
7Hadden RD, Comblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome.Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group[J].Ann Neurol, 1998,44(5) :780-788.
-
8Cheng BC, Chang WN, Chen JB, et al. Long term prognosis for Guillain-Barre syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis[J] .J Clin Aphere 2003, 18(4):175-180.
-
9Lyu RL, Chela WH, Hsien ST. Plasma Exchange versus double filtration plasmapheresis in the treatment of Guillain-Barre syndrome[J]. Ther Apher,2002,6(2) : 163-166.
-
10Haupt WT. Recent advances of therapeutic apheresis in Guillain-Barre syndrome[J] .Ther Apher,2000,4(4): 271-274.
-
1TsRavnborg M SФ rensen PS Andersson M.β干扰素联合甲泼尼龙治疗复发缓解型多发性硬化效果不佳[J].中国处方药,2010(7):59-59.
-
2刘学忠,崔旭,卞建春,任建新,刘宗平,王捍东,王宗元.硫辛酸在大鼠全脑缺血再灌注损伤中的神经保护作用[J].中国兽医学报,2004,24(4):388-390. 被引量：9
-
3张婧婧,闫福岭.步长脑心通防治血管性痴呆的临床研究进展[J].现代医学,2010,38(3):320-323. 被引量：7
-
4王大力,张江,李国荣,赵晓晶,张丽,高素玲,薛新宏.早期规范三级康复治疗对缺血性脑卒中患者临床疗效观察[J].中国实用神经疾病杂志,2010,13(3):56-58. 被引量：12
-
5曾丽莉,陈生弟.多发性硬化治疗新进展[J].世界临床药物,2005,26(4):224-228. 被引量：5
-
6赵立军,柴丽丽.不同亚型的青年脑梗死患者预后的差别及其影响因素[J].癫痫与神经电生理学杂志,2015,24(6):343-346. 被引量：1
-
7李馨,李天明.评价不同治疗方案对多发性硬化的疗效及不良反应[J].中国农村卫生,2016,8(09X):10-11.
-
8韩莹,马爱军,王源,王琨,范凌燕,姜雪松,伊朋,李翠玲,刘世海,姚如永,潘旭东.缺血性脑卒中及不同亚型与血浆脂蛋白相关磷脂酶A2水平及其基因I198T多态性的关系[J].临床神经病学杂志,2013,26(3):169-172. 被引量：7
-
9李水彬,黄秉钦,梁志安,侯飞雁,俞万香,叶艳玉.β干扰素鞘内注射治疗多发性硬化的临床研究[J].中国基层医药,2003,10(10):1004-1005. 被引量：2
-
10王立平,崔青.托吡酯添加治疗部分性癫癎发作对照研究[J].中国综合临床,2004,20(6):500-502.
